Hospitalized ElderlyPhase 3NCT01626742
A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study
A Phase 3 study testing Ready to Drink Flavored Beverage and Ready to drink flavored beverage w/ AN 777 in people with Hospitalized Elderly, run by Abbott Nutrition at 119 sites in 2 countries.
Trial summary
Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Hospitalized Elderly
- What is being tested?
- Ready to Drink Flavored Beverage and Ready to drink flavored beverage w/ AN 777
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 652 participants
- Where
- 119 sitesin 2 countries
- Study dates
- May 2012to Oct 2014
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Male or female ≥ 65 years of age.
- Admitted to hospital with diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease.
- Subjective Global Assessment rating of B or C.
- Length of hospital stay anticipated to be > 3 days and < 12 days
- Able to consume foods and beverages orally.
- Functionally ambulatory during the 30 days prior to admission.
Who cannot join
- Uncontrolled hypertension
- Diagnosis of diabetes
- Current active cancer or recently treated cancer
- Impaired renal function
- Liver failure, acute Hepatitis, or hepatic encephalopathy
- Active tuberculosis.
Show all 15Show fewer
- HIV
- Disorder of gastrointestinal tract
- Autoimmune disorder
- Intubation, and/or tube or parenteral feeding.
- Severe dementia or delirium, brain metastases, eating disorder, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures
- Allergy or intolerance to any of the ingredients in the study products.
- Body mass index of ≥ 40 kg/m2.
- Resident in a nursing home or other residential facility.
- Planned surgery during course of the study.
Trial locations and contacts
119 sites in 2 countries.
119 sites in 2 countries
United States115 sites
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, 87131
Mission Hospital
Asheville, North Carolina, 28801
King's Daughters Medical Center, Kentucky Heart Foundation , Inc.
Ashland, Kentucky, 41101
Emory University
Atlanta, Georgia, 30303
Emory University Hospital
Atlanta, Georgia, 30322
ZASA Clinical Research
Atlantis, Florida, 33462
Auburn University
Auburn, Alabama, 36849
Maine Research Associates
Auburn, Maine, 04210
Aurora Denver Cardiology Associates, PC
Aurora, Colorado, 80012
MedStar Health Research Institute - MedStar Union Memorial Hospital
Baltimore, Maryland, 21218
Johns Hopkins University Hospital
Baltimore, Maryland, 21287
Eastern Maine Medical Center
Bangor, Maine, 04401
The Hope Heart Institute
Bellevue, Washington, 98004
Birmingham Heart Clinic
Birmingham, Alabama, 35235
Visions Clinical Research, LLC
Boynton Beach, Florida, 33472
Pulmonary and Sleep of Tampa Bay
Brandon, Florida, 33511
Erie County Medical Center
Buffalo, New York, 14215
PMG research of Charleston
Charleston, South Carolina, 29407
Medical University of South Carolina
Charleston, South Carolina, 29425
Northwestern University
Chicago, Illinois, 60611
University of Illinois at Chicago
Chicago, Illinois, 60641
The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital
Cincinnati, Ohio, 45219
Morton Plant Mease HealthCare
Clearwater, Florida, 33756
MetroHealth Medical Center
Cleveland, Ohio, 44109
Kootenai Heart Clinics, LLC
Coeur d'Alene, Idaho, 83814
Texas A&M University
College Station, Texas, 77843
Palmetto Senior Primary Care Practice
Columbia, South Carolina, 29203
Columbus Regional Research Institute
Columbus, Georgia, 31904
Riverside Methodist Hospital
Columbus, Ohio, 43214
Atlanta Institute for Medical Research
Decatur, Georgia, 30030
Seidman Clinical Trials
Delray Beach, Florida, 33484
Doylestown Hospital
Doylestown, Pennsylvania, 18901
North Ohio Research
Elyria, Ohio, 44035
Physician Specialists of Northern Lancaster County Medical Group
Ephrata, Pennsylvania, 17522
Sanford Clinic North-Fargo
Fargo, North Dakota, 58122
UConn Health Center
Farmington, Connecticut, 06030
Hunterdon Cardiovascular Associates
Flemington, New Jersey, 08822
McLaren-Flint Research Institute
Flint, Michigan, 48532
Broward Health - Broward General Medical Center
Fort Lauderdale, Florida, 33316
UCSF Fresno
Fresno, California, 93701
St. Jude Medical Center
Fullerton, California, 92835
University of Florida
Gainesville, Florida, 32611
Glendale Adventist Medical Center
Glendale, California, 91206
East Carolina University
Greenville, North Carolina, 27834
St John Hospital & Medical Center
Grosse Pointe Woods, Michigan, 48236
Hackensack University Medical Center
Hackensack, New Jersey, 07601
Research Concierge, LLC
Hartford, Kentucky, 42347
Kentucky Lung Clinic
Hazard, Kentucky, 41701
In Vivo Clinical Research
Hialeah, Florida, 33010
Edward Hines VA Hospital
Hines, Illinois, 60141
Heart Center Research, LLC
Huntsville, Alabama, 35801
St Vincent Medical Group
Indianapolis, Indiana, 46290
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242
River City Clinical Research
Jacksonville, Florida, 32207
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216
Bronson Healthcare Group
Kalamazoo, Michigan, 49007
eStudySite, La Mesa
La Mesa, California, 91942
South Orange County Surgical Medical Group
Laguna Hills, California, 92653
The Cardiovascular Center, P.A.
Lake Mary, Florida, 32746
Watson Clinic Center for Research, Inc.
Lakeland, Florida, 33805
Largo Medical Center
Largo, Florida, 33770
eStudySite, Las Vegas
Las Vegas, Nevada, 89109
Tanner Clinic
Layton, Utah, 84041
Baptist Health Center for Clinical Research
Little Rock, Arkansas, 72205
Jewish Hospital & St Mary's Healthcare
Louisville, Kentucky, 40202
Medical Center of the Rockies
Loveland, Colorado, 80538
Panama Clinical Research Associates
Lynn Haven, Florida, 32444
Activmed Practices & Research, Inc
Methuen, Massachusetts, 01844
University of Miami Miller School of Medicine
Miami, Florida, 33136
Cuervo Clinical Research Group, Inc
Miami, Florida, 33143
Health & Life Research Solutions Inc.
Miami, Florida, 33173
Novo Research dba FCPP Research
Modesto, California, 95350
HealthScan Research
Montgomery, Alabama, 36106
Virtua Medical Group
Moorestown, New Jersey, 08057
STHS Heart, LLC
Nashville, Tennessee, 37205
Vanderbilt University Medical Center
Nashville, Tennessee, 37232
Ochsner Medical Center
New Orleans, Louisiana, 70121
Columbia University Medical Center
New York, New York, 10032
Sentara Cardiovascular Research Institute
Norfolk, Virginia, 23507
Ocala Research Institute, Inc.
Ocala, Florida, 34471
eStudySite, Oceanside
Oceanside, California, 92056
Alegent Creighton Health Heart & Vascular Specialists
Omaha, Nebraska, 68124
Creighton University
Omaha, Nebraska, 68178
Pulmonary Consultant & Primary Physicians Medical Group
Orange, California, 92868
Cardiovascular Institute of Northwest Florida
Panama City, Florida, 32401
Cardiology Consultants
Pensacola, Florida, 32501
Drexel University College of Medicine
Philadelphia, Pennsylvania, 19102
Advanced Clinical Research Associates
Plano, Texas, 75093
David M Headley
Port Gibson, Mississippi, 39150
VA Sierra Nevada Health Care System
Reno, Nevada, 89502
Carilion Medical Center Geriatrics
Roanoke, Virginia, 24014
Rochester General Hospital
Rochester, New York, 14621
Crittenton Hospital Medical Center
Rochester Hills, Michigan, 48307
William Beaumont Hospital
Royal Oak, Michigan, 48073
HealthEast St Joseph's Hospital
Saint Paul, Minnesota, 55102
Salem VA Medical Center
Salem, Virginia, 24153
South Texas Cardiovascular Consultants
San Antonio, Texas, 78201
Sonterra Clinical Research
San Antonio, Texas, 78205
Sonterra Clinical Research
San Antonio, Texas, 78258
Donald Guthrie Foundation for Education and Research, Inc.
Sayre, Pennsylvania, 18840
Scottsdale Healthcare
Scottsdale, Arizona, 85260
Grand View Hospital Clinical Research
Sellersville, Pennsylvania, 18960
Louisiana State University Health Science Center
Shreveport, Louisiana, 71103
Sanford Clinic Family Medicine
Sioux Falls, South Dakota, 57106
Regenerate Clinical Trials
South Miami, Florida, 33143
Baystate Medical Center
Springfield, Massachusetts, 01199
St Anthony's Medical Center
St Louis, Missouri, 63128
Advanced Clinical Research Group
Stuart, Florida, 34996
Los Angeles Biomedical Research Institution
Torrance, California, 90502
Associated Cardiovascular Consultants of Lourdes
Voorhees Township, New Jersey, 08043
Cardiology Partners Clinical Research Institute
Wellington, Florida, 33449
The Reading Hospital and Medical Center
West Reading, Pennsylvania, 19611
Novant Clinical Research Institute
Winston-Salem, North Carolina, 27103
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
Pinnacle Health Cardiovascular Institute, Inc.
Wormleysburg, Pennsylvania, 17043
Puerto Rico4 sites
San Juan Bautista School of Medicine
Caguas, 00725
Western Cardiovascular Surgery of Puerto Rico
Mayagüez, 00680
Research and Cardiovascular Corp
Ponce, 00717
VA Caribbean Healthcare System
San Juan, 00921
About this study
Official title: A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients.
- Conditions
- Hospitalized Elderly
- Being tested
- Ready to Drink Flavored Beverage, Ready to drink flavored beverage w/ AN 777
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ready to Drink Flavored BeverageOther
2 servings a day
Ready to drink flavored beverage w/ AN 777Other
2 servings a day
| Study group | Role | What they receive |
|---|---|---|
| Ready to drink flavored beverage | Placebo comparator | Not described Receives: Other: Ready to Drink Flavored Beverage |
| Ready to drink flavored beverage w/ AN 777 | Experimental | Not described Receives: Other: Ready to drink flavored beverage w/ AN 777 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Return to hospital or death
Measured: 90 days
Secondary outcomes (3)
Return to hospital or death
Measured: 30 and 60 days
Hospital Days
Measured: 90 days
Activities of Daily Living
Katz Activities of Daily Living at entry and 90 days
Measured: 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jun 2012 (estimated)
- Study startMay 2012
- Primary completionOct 2014
- Study completionOct 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Hospitalized ElderlyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 652 participants (actual)
Sponsor and investigators
- Lead sponsor
- Abbott Nutrition
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Menghua Luo, MD, PhD, Study chair, Abbott NutritionJeffrey Nelson, PhD, Study chair, Abbott Nutrition
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01626742
- Sponsor's protocol ID
- BL01
- Status last verified
- Apr 2015
- First submitted
- 21 Jun 2012
- Last updated
- 28 Apr 2015
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Baggs GE, Middleton C, Nelson JL, Pereira SL, Hegazi RM, Matarese L, Matheson E, Ziegler TR, Tappenden KA, Deutz N. Impact of a specialized oral nutritional supplement on quality of life in older adults following hospitalization: Post-hoc analysis of the NOURISH trial. Clin Nutr. 2023 Nov;42(11):2116-2123. doi: 10.1016/j.clnu.2023.09.004. Epub 2023 Sep 9.
PubMed 37757502Matheson EM, Nelson JL, Baggs GE, Luo M, Deutz NE. Specialized oral nutritional supplement (ONS) improves handgrip strength in hospitalized, malnourished older patients with cardiovascular and pulmonary disease: A randomized clinical trial. Clin Nutr. 2021 Mar;40(3):844-849. doi: 10.1016/j.clnu.2020.08.035. Epub 2020 Sep 5.
PubMed 32943241Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR; NOURISH Study Group. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial. Clin Nutr. 2016 Feb;35(1):18-26. doi: 10.1016/j.clnu.2015.12.010. Epub 2016 Jan 18.
PubMed 26797412
Study at a glance
From the registry record, last updated by the sponsor on 28 Apr 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
- ClinicalTrials.gov ID
- NCT01626742
- Acronym / sponsor ID
- BL01
- Conditions
- Hospitalized Elderly
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 652 participants (actual)
- Lead sponsor
- Abbott NutritionIndustry (pharma, biotech, devices)
- Study start
- May 2012
- Primary completion
- Oct 2014 (actual)
- Study completion
- Oct 2014 (actual)
- First posted
- 25 Jun 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ready to drink flavored beverage | Placebo comparator | Other: Ready to Drink Flavored Beverage |
| Ready to drink flavored beverage w/ AN 777 | Experimental | Other: Ready to drink flavored beverage w/ AN 777 |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (6 listed)
- Male or female ≥ 65 years of age.
- Admitted to hospital with diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease.
- Subjective Global Assessment rating of B or C.
- Length of hospital stay anticipated to be > 3 days and < 12 days
- Able to consume foods and beverages orally.
Key exclusion criteria (15 listed)
- Uncontrolled hypertension
- Diagnosis of diabetes
- Current active cancer or recently treated cancer
- Impaired renal function
- Liver failure, acute Hepatitis, or hepatic encephalopathy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ready to Drink Flavored Beverage2 servings a day | Other | Ready to drink flavored beverage |
| Ready to drink flavored beverage w/ AN 7772 servings a day | Other | Ready to drink flavored beverage w/ AN 777 |
Primary outcome
Return to hospital or death
Time frame: 90 days
3 secondary outcomes
Return to hospital or death
Time frame: 30 and 60 days
Hospital Days
Time frame: 90 days
Activities of Daily Living
Time frame: 90 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Apr 2015.
- Derived from this study: PubMed 37757502Baggs GE, Middleton C, Nelson JL, Pereira SL, Hegazi RM, Matarese L, Matheson E, Ziegler TR, Tappenden KA, Deutz N. Impact of a specialized oral nutritional supplement on quality of life in older adults following hospitalization: Post-hoc analysis of the NOURISH trial. Clin Nutr. 2023 Nov;42(11):2116-2123. doi: 10.1016/j.clnu.2023.09.004. Epub 2023 Sep 9.
- Derived from this study: PubMed 32943241Matheson EM, Nelson JL, Baggs GE, Luo M, Deutz NE. Specialized oral nutritional supplement (ONS) improves handgrip strength in hospitalized, malnourished older patients with cardiovascular and pulmonary disease: A randomized clinical trial. Clin Nutr. 2021 Mar;40(3):844-849. doi: 10.1016/j.clnu.2020.08.035. Epub 2020 Sep 5.
- Derived from this study: PubMed 26797412Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR; NOURISH Study Group. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial. Clin Nutr. 2016 Feb;35(1):18-26. doi: 10.1016/j.clnu.2015.12.010. Epub 2016 Jan 18.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Menghua Luo, MD, PhD study chair
Abbott Nutrition
Jeffrey Nelson, PhD study chair
Abbott Nutrition
119 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Ready to Drink Flavored Beverage and Ready to drink flavored beverage w/ AN 777 in people with Hospitalized Elderly, run by Abbott Nutrition at 119 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 119 sites in United States, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Return to hospital or death (time frame: 90 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01626742, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2015.